Community News

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve appoints Peter L. Spadaro Chief Commercial Officer

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Rad-G™, which provides spot-checking and continuous monitoring with SET® pulse oximetry and other parameters, has received FDA clearance.

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings Inc., a leading consumer-focused digital healthcare platform in the United States, today announced the closing of its initial public offering of 39,807,691 shares of its Class A common stock at a price to the public of $33.00 per share. Of the offered shares, 28,615,034 shares were offered by GoodRx and 11,192,657 shares were offered by certain selling shareholders. The number of shares offered and sold by GoodRx included the exercise in fu

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead reports inducement grants

CHATSWORTH, Calif.--(BUSINESS WIRE)-- #19DaysofGratitude--Careismatic Brands, the world’s largest designer and manufacturer of medical apparel, today announced the launch of a global tribute and charitable fundraising campaign, “19 Days of Gratitude,” spotlighting the heroism of nurses as they continue to battle COVID-19 on the front lines. Launching in a year that the World Health Organization has deemed “The International Year of The Nurse and Midwife,” and timed to the 200th […]

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has made the decision to institute a review regarding the validity of six Medtronic patents that Axonics is contesting. On March 16,

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #INDstatus--PharmaCyte Biotech engages with the FDA regarding its IND submission. We anticipated a number of engagements to supplement key information to our IND,

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interfaces (APIs) that will offer provider and revenue cycle organizations connectivity to payers via the NaviNet Open Platform. This update enables faster information retrieval and easier payer access through a secure real-time, HIPAA-compliant gateway to payers. The workflows include Eligibility […]

IRVINE, Calif.--(BUSINESS WIRE)-- #COVID19--While studying the genetics of the androgen receptor, a team of scientists discovered a possible breakthrough treatment for COVID-19. The team led by Andy Goren, MD from Applied Biology, Flavio A. Cadegiani, MD, MSc, PhD from Corpometria Institute in Brazil, along with other collaborators, have published their discovery in several medical journals. The manuscript, “What Does Androgenetic Alopecia have to do with COVID-19? An Insight into a Potential […]

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has partnered with a large pharmaceutical company to validate the AIDD Module in ADMET Predictor 10.0 (APX).

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the resumption of its Early Feasibility Study of the Orion® Visual Cortical Prosthesis System (“Orion”) at UCLA Medical Center (“UCLA”). The study, which includes four participants at UCLA and two participants at Baylor College of […]

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--City of Hope licensed intellectual property relating to its chlorotoxin chimeric antigen receptor T cell therapy to Chimeric Therapeutics Limited.

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, today announced that Health Canada has approved its next generation rechargeable implantable neurostimulator (INS) for the Axonics r-SNM® System. The next generation INS approved by Health Canada reduces how frequently a patient needs to re

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--A phase 1 clinical trial of AMG 510 in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity.

LOS ANGELES--(BUSINESS WIRE)-- #COVID19--DeciBio Consulting, a strategy consulting firm dedicated to the precision medicine space, has launched the Emmes SARS-CoV-2 Testing Database. This database serves as the latest addition to the market intelligence products already under DeciBio Consulting’s umbrella. Such products include the Emmes Infectious Disease Database, the Emmes Oncology Database, BioMAP (immuno-oncology biomarkers), Marketbooks, Dexter, and BioTrack, among others. The DeciBio […]

LOS ANGELES--(BUSINESS WIRE)-- #KOL--DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, a precision medicine strategy consulting firm, has launched an expert network marketplace named Dexter. The launch follows Dexter’s successful beta release a year ago. Dexter customers receive market intelligence by leveraging Dexter’s life science expert network for 1:1 interviews and pulse surveys. Dexter offers an end to end research project solution, from finding relevant […]

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today highlighted that Orphayzme A/S (“Orphazyme”) announced that the U.S. Food and Drug Administration (“FDA”) has accepted, with Priority Review, the company’s New Drug Application (“NDA”) for arimoclomol for the treatment of Niemann-Pick disease Type C (“NPC”). The FDA grants Priority Review […]

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, today announced that Raymond W. Cohen, Axonics CEO, has been named an Ernst & Young Entrepreneur of the Year 2020 Award finalist for Orange County. The Entrepreneur of the Year program honors entrepreneurial business leaders whose visio

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead positive interim 24-week liver biopsy clinical trial results for ARO-AAT in alpha-1 antitrypsin deficiency improves Key Parameters

IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment Conferences